Edible Mushrooms and Beta-Glucans: Impact on Human Health

23 July 2026
Ali Alawadhi
Edible Mushrooms and Beta-Glucans: Impact on Human Health

Abstract

  • Background

Mushroom cell walls are exceptionally rich sources of bioactive $\beta$-glucans, which are complex glucose polymers structured around $\beta$-(1$\to$3) main chains with $\beta$-(1$\to$6) linked branching points, contrasting structurally with linear cereal-derived $\beta$-glucans lacking 1,6 linkages and branching configurations. Preclinical cellular and experimental models have extensively demonstrated both robust immunomodulatory and anti-inflammatory properties associated with purified fungal $\beta$-glucans and whole extracts, leading to their clinical investigation in diverse conditions such as recurrent respiratory tract infections and post-surgical recovery complications. Furthermore, mushroom-derived $\beta$-glucans exhibit promising adjunctive potential in oncology alongside conventional chemotherapy. While cardiovascular protective benefits—including the amelioration of glucose metabolism, lipid profiles, and blood pressure regulation—are well-documented for oat and barley $\beta$-glucans, targeted human clinical confirmation specifically utilizing mushroom $\beta$-glucans remains an area of ongoing research. Additionally, mushrooms protect the cardiovascular and metabolic systems through a synergistic matrix of bioactive phenolic compounds, essential vitamins, and trace minerals. Expanding scientific insight into these molecular mechanisms and health benefits is actively driving the clinical translation of $\beta$-glucans as evidence-based prophylactic and therapeutic nutraceuticals within healthy lifestyle frameworks.

  • Methods

A comprehensive literature evaluation was conducted across major scientific databases—including PubMed, Scopus, Web of Science, and Embase—focusing on peer-reviewed pharmacological analyses, biochemical extractions, structural comparisons between cereal and fungal $\beta$-glucans, in vitro cellular assays, in vivo animal investigations, and human clinical trials. Data extraction prioritized examining molecular weight variations, $\beta$-(1$\to$3) and $\beta$-(1$\to$6) glycosidic branching configurations, cellular receptor interactions, immunomodulatory efficacy, oncological adjunctive outcomes, and cardiometabolic health parameters.

  • Results

The synthesized clinical and preclinical evidence confirms that mushroom-derived $\beta$-glucans and whole extracts exert profound multi-systemic physiological effects:

Structural Distinctiveness & Immunomodulation: Fungal $\beta$-glucans, characterized by their unique $\beta$-(1$\to$3, 1$\to$6) branching structures, effectively interact with pattern recognition receptors on immune cells to elicit potent immunomodulatory and anti-inflammatory responses.

Clinical Efficacy in Infections & Surgery: Purified mushroom $\beta$-glucans and fungal extracts demonstrate proven clinical utility in mitigating recurrent respiratory tract infections and reducing complications following major surgical interventions.

Oncological Adjunctive Potential: Emerging evidence supports the exploration of $\beta$-glucans as safe, effective biological response modifiers and adjuvants alongside conventional cancer chemotherapy protocols.

Cardiometabolic & Synergistic Protection: While metabolic and cardiovascular benefits (such as improved lipid and glucose regulation) are established for cereal $\beta$-glucans, whole mushrooms provide comprehensive cardiovascular support through combined $\beta$-glucans, bioactive phenolics, vitamins, and minerals.

Safety & Tolerability: Mushroom extracts and $\beta$-glucan interventions maintain an exemplary safety profile and high biological tolerability across human studies.

  • Conclusions

Mushroom cell wall $\beta$-glucans—distinguished by their complex $\beta$-(1$\to$3, 1$\to$6) linkages—serve as powerful biological response modifiers capable of modulating immune function, supporting infection resistance, and acting as promising adjunctive agents in cancer and cardiometabolic care. Continued clinical documentation of their health benefits reinforces their vital role in preventive medicine and disease-prevention strategies embedded within healthy lifestyles.


https://pmc.ncbi.nlm.nih.gov/articles/PMC8308413/